Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Farudodstat may help treat alopecia areata by protecting hair follicles.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Concurrent laser and isotretinoin treatment improves acne scars more than delayed treatment.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Low-level laser therapy reduces symptoms and inflammation in frontal fibrosing alopecia.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

Flutamide alone is as effective as the combination with finasteride for treating hirsutism.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Tofacitinib may help treat severe hair loss, but more research is needed.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Dupilumab may help regrow hair in people with atopic dermatitis.